An interventional study of Freeze-dried grape powder and Placebo powder in Obesity &Amp; Overweight, sponsored by University of Missouri-Columbia. Recruiting at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by University of Missouri-Columbia · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Obesity by University of Missouri-Columbia — 8 open to participants now, 9 under way, none of them phase 3. Obesity · University of Missouri-Columbia.
Among the 34 studies in Obesity by University of Missouri-Columbia, this one is the 13th largest by planned enrollment of the 29 interventional ones that give a count, is one of 4 that started in 2025, is one of 21 with no phase, and was the 31st registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →8 of the 34 studies in Obesity by University of Missouri-Columbia are open now, in 1 country. Recruiting first, the newest first:
University of Missouri-Columbia · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
University of Missouri-Columbia · Sites in United States
Ages 18–59 · Healthy volunteers
University of Missouri-Columbia · Sites in United States
Ages 18–45 · Healthy volunteers
University of Missouri-Columbia · Sites in United States
Ages 18–45 · Healthy volunteers
University of Missouri-Columbia
Ages 18–65 · Healthy volunteers
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 2 · Phase 3 1
First in 2007; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 40 across the 29 interventional studies, 25 across the 5 observational. Of the 22 that completed or were terminated, 8 (36%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Missouri-Columbia is the lead sponsor of 365 studies on the registry; 69 are open to participants now.
Of its 43 completed or terminated interventional studies of FDA-regulated products, 29 (67%) have results posted.
2 of the studies in Obesity by University of Missouri-Columbia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06791837University of Missouri-ColumbiaBrain Blood Flow and Lactate in Non-obese and Obese Subjects | 2027-03-01 |
| NCT05219799University of Missouri-ColumbiaSex Disparities in Hypoxic Vasodilation and Impact of Obesity | 2027-07-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 34 studies in Obesity by University of Missouri-Columbia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.
The study is a 12-wk randomized, controlled, crossover trial. Participants will be randomized to one of two intervention sequences, either consuming 48g/day of whole freeze-dried grape powder followed by an isocaloric placebo powder or consuming the placebo powder followed by the whole freeze-dried grape powder. Active intervention phases will be 4 weeks in duration followed by a 4-week washout period between treatments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Whole freeze-dried grape powder for 4 weeks, 4-week washout, then isocaloric placebo powder for 4 weeks.
Other: Freeze-dried grape powder · Other: Placebo powder
Isocaloric placebo powder for 4 weeks, 4-week washout, then whole freeze-dried grape powder for 4 weeks.
Other: Freeze-dried grape powder · Other: Placebo powder
48 g/day oral consumption during the 4-week active period.
Isocaloric placebo matched to grape powder; oral consumption during the 4-week active period.
Gut microbial diversity
Assessed via 16s rRNA sequencing
Time frame: Baseline, Week 4, Week 8, Week 12
LPS-binding protein concentration
Intestinal permeability marker
Time frame: Baseline, Week 4, Week 8, Week 12
Cytokine concentrations following PBMC stimulation
IL-6, IL-10
Time frame: Baseline, Week 4, Week 12
Perceived stress score
Assessed using validated Cohen's Perceived Stress Scale. Scores range from 0-56 with higher scores indicating greater stress perceptions.
Time frame: Baseline, Week 4, Week 8, Week 12
Gut microbiome abundance
Assessed via 16s rRNA sequencing
Time frame: Baseline, Week 4, Week 8, Week 12
Inflammatory Markers
IL-6, IL-10, TNF-alpha, IFN-gamma
Time frame: Baseline, Week 4, Week 8, Week 12
Body mass
Measured in kg
Time frame: Baseline, Week 4, Week 8, Week 12
Body composition
Fat mass and fat-free mass
Time frame: Baseline, Week 4, Week 8, Week 12
Anthropometrics
Waist circumference, hip circumference, thigh circumference
Time frame: Baseline, Week 4, Week 8, Week 12
Glucoregulation
Fasting glucose concentrations
Time frame: Baseline, Week 4, Week 8, Week 12
Insulinemic biomarker concentrations
Insulin concentrations
Time frame: Baseline, Week 4, Week 8, Week 12
Lipid profile
LDL, HDL, triglycerides, total cholesterol
Time frame: Baseline, Week 4, Week 8, Week 12
Blood pressure
Diastolic and systolic blood pressure
Time frame: Baseline, Week 4, Week 8, Week 12
Dietary intake using 24-hour recalls
24-hour diet recall using Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA-24).
Time frame: Every week
Physical activity
Activity assessment using Actigraphs
Time frame: Baseline, Week 4, Week 8, Week 12
Sleep indices from Actigraphs
Assessed using Actigraphs
Time frame: Baseline, Week 4, Week 8, Week 12
24-hour appetite ratings
24-hour appetite ratings assessed using Visual Analog Scale. For each question scores range from 0-100 with higher scores indicating "extremely" and lower scores indicating "not at all."
Time frame: Baseline, Week 4, Week 8, Week 12
Palatability rating of foods
Hedonic general labelled magnitude scale (gLMS). Scores range from 0 to 100.
Time frame: Every week
Acceptance rating of foods
9-point food action rating scale (1-9) with higher scores indicating a higher food rating.
Time frame: Every week
Dietary Intake over past month
Assessed using Food Frequency Questionnaires
Time frame: Baseline, Week 4, Week 8, Week 12
IPAQ Score
Measured using the International Physical Activity Questionnaire (IPAQ). Activity levels categorized as high, moderate, or low based on IPAQ scoring procedure.
Time frame: Baseline, Week 4, Week 8, Week 12
Sleep indices from sleep diary
Assessed using sleep diary
Time frame: Baseline, Week 4, Week 8, Week 12
Memory indices
Assessed using memory tests
Time frame: Baseline, Week 4, Week 8, Week 12
Attention indices
Assessed using d2 test of attention
Time frame: Baseline, Week 4, Week 8, Week 12
Plan to share: Yes — Individual participant data that underlie the results reported here after deidentification (ie; text, tables, figures, and appendices)
Supporting information: Study protocol
Time frame: Immediately following publication. No end date.
Access criteria: Data will be deposited in online repositories
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Dec 2027, 24 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 24 months is close to that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Missouri-Columbia →